IN THE 20 years prior to 1983 the overall death rate for the cardiovascular diseases declined an impressive 36% nationwide. The rate per year.declined in 18 of these years, declining 1.5% per year between 1963 and 1973 and 3.3% per year since then. Because this group of iiseases accounts for one-half of all deaths, a death rate that is 36% lower in 1982 than in 1963 translates into about 500,000 fewer deaths in 1982 than would have been projected based on rates in 1963. This improvement in cardiovascular mortality is the main reason that total mortality has declined 26% since 1963 and that average life expectancy at age 35 increased 2.6 years during the 10 years from 1972 to 1982, a greater increase than during any decade since vital statistics were first published in 1900.
Of even greater significance is the remarkable reversal in the death rate trend for the major cardiovascular subgrouip, coronary heart disease. From an epidemic rise in the rate until the mid-1960s, the trend turned downwards and declined 37% between 1963 and 1982 (figure 1 ). There has also been marked acceleration in the downward trend since 1972 for stroke and all cardiovascular diseases.
It is still essentially unknown, however, whether these declines in mortality are occurring more in hospitalized or in nonhospitalized segments of the population, i.e., whether declines are occurring in the incidence of new cases or whether there has been a change in the prognosis, severity, case-fatality, and survivorship after development of cardiovascular disease. These major gaps in knowledge stand in the way of determrining causes of the decline in cardiovascular mortality. Even if such information can be obtained, determining causation would still be difficult if the declines were due primarily to factors not specific to the cardiovascular diseases; e.g., factors such as a better standard of living, greater awareness of health hazards, healthier lifestyles, better nutrition, or better and wider use of medical care. Some researchers favor this conclusion because the improvement has been ubiquitous. Also, as yet no one can unequivocally and directly associate specific improvements in cardiovascular disease prevention and treatment with the mortality decline. Many other researchers, ourselves included, believe that such associations, as incomplete, indirect, and equivocal as they are, are substantial enough to suggest that the beneficial changes that have taken place in cardiovascular health habits, risk factor levels, and preventive medicine, as well as in medical management of the disease, have indeed contributed to the decline in mortality.2'8 It is possible, of course, that both views are correct.
Clearly, the mortality declines are a break from past trends, are real, substantial, and sustained over the long term, and they are accompanied by a decline in total mortality. This rules out factors such as short cyclical trends in death rates or artifacts in vital statistics and cause-of-death determinations. Such an improvement in mortality for a major chronic disease suggests that some type of breakthrough in prevention and treatment of cardiovascular diseases has been made. Here we review arguments for and against this conclusion, assess the relative impacts on the decline attributed to various prevention and treatment factors, and discuss the implications of our conclusions.
Significant mortality patterns
Although historically the causes of most mortality trends have never been well explained, many unusual features of current Primary prevention. Epidemiologic studies have provided evidence that faulty health habits typified by a diet excessive in calories, fat, and salt, sedentary habits, unrestrainted weight gain, and cigarette smoking predispose to coronary heart disease. Related risk factors, especially increased serum cholesterol, blood glucose, and blood pressure are also associated with increased incidence of coronary events, including fatal attacks. There is ample evidence that the nation as a whole has reduced levels of these risk factors during the past 20 years, the period during which the coronary heart disease death rate has declined. Evidence that control of hypertension is an important contributor to the decline in mortality is especially strong because hypertension is one of the major risk factors for stroke, cardiac failure, and coronary heart disease. Death from hypertension-related diseases has shown the steepest decline, and declines in incidence of stroke are seen particularly in women, who have shown the greatest improvement with respect to awareness of hypertension and seeking treatment. Although some may question whether control of hypertension has been shown to reduce coronary mortality, it has been unequivocally demonstrated that morbidity and mortality from stroke and congestive heart failure is distinctly improved. The dramatic acceleration in the rate of decline in stroke mortality around 1973, when major strides were being made in the detection and control of hypertension, stands as testimony to the efficacy of control of hypertension in primary prevention of cardiovascular catastrophies. Cigarette smoking has been shown unequivocally to increase risk of myocardial infarction or sudden death, and there is a prompt and dramatic decline in risk of disease or death on cessation. Between 1965 and 1980 there has been a reduction of 25% in the proportion of male smokers and a 14% reduction for female smokers, coinciding over time with the coronary heart disease mortality declines. It is noteworthy that before the Surgeon General's Report on Smoking and Health in 1964 there was a general and rapid rise in mortality from coronary heart disease, lung cancer, and emphysema. Subsequent to 1964, coronary heart disease mortality declined promptly and rapidly and we are now observing declines in mortality for lung cancer and emphysema in young adult men, a slowing of the rise in older men, and a continued rise for women. This pattern is consistent with an impact of smoking patterns on mortality.
Between pears to be the most likely cause for the high blood lipid levels so fundamental in the atherosclerotic process and it also plays a prominent role in hypertension through obesity and high salt intake. The American public has become more aware of the health implications of overeating, and coincident with this, cholesterol levels have declined along with per capita consumption of milk, butter, eggs, and animal fats. Trends are following the direction predicted by the diet-heart theory in the United States, Australia, and in Finland, but the picture is anomalous in Japan and Switzerland.
Obesity promotes all the atherogenic traits, including hypercholesterolemia, very low-density lipoprotein excess, hyperglycemia, hypertension, a rise in low-density lipoprotein level, and lowering of highdensity lipoprotein cholesterol level. The lipid changes induced result in a less favorable low-density lipoprotein/high-density lipoprotein ratio, reflecting the twoway traffic of cholesterol entering and leaving the tissues. The proportion of overweight persons in the population has declined although average weight has increased. 2 Evidence that primary prevention has played a role in declines in coronary heart disease mortality has also been reported for other countries. In Australia and New Zealand, where coronary trends are quite similar to those in the United States, changes in health habits and risk factors appear to parallel changes in coronary mortality.2 Dietary changes in Australia are similar to those in the United States and there is some leveling off of tobacco use. In New Zealand diet, serum cholesterol levels, and cigarette smoking habits are improving. The mortality decline has been associated with a decrease in the consumption of dairy products and more recently with an increased awareness of the importance of treating hypertension, and there has also been an apparent increase in physical exercise in the community. Changes between 1949 and 1977 in fat consumption in Israel are correlated with trends in coronary heart disease mortality.
Without knowing if the incidence or severity of coronary attacks is declining along with mortality one cannot be certain that improvements with respect to risk factor levels, health habits, or other types of primary prevention have contributed to the mortality decline. There is evidence from studies of male employees of the DuPont Company, of hospitalized patients in the Kaiser-Permanente Medical Care Program in San Francisco, and of hospitalized patients in the Minnesota Heart Survey that the incidence of coronary heart disease is declining. There Improvement in the hospital case-fatality rate for coronary patients is reported in the Minnesota Heart Survey, the DuPont Study, the Rochester, Minnesota Study, and the National Hospital Discharge Survey. 2 The findings suggest that hospital mortality rates are improving, but that the impact on overall coronary heart disease mortality can only be modest because such a great proportion of the deaths occur suddenly outside the hospital.
In general, there is a gap between the theoretical benefits of medical therapy based on results in selected patients in clinical trials and the actual impact that advances in this area have actually had on the general population. Dramatic improvement in in-hospital treatment can have only a limited impact on death and disability rates, since so much of the mortality rate reflects immediate death and because, once an infarction occurs, the heart and brain have an innately limited capacity for recovery.
Unresolved issues
Arguments opposing the view that "breakthroughs" in prevention and treatment of cardiovascular disease caused or contributed to the declines in mortality rest on the inconsistencies in and incompleteness and limitations of trend statistics in support of the breakthrough view and on some trend data that support the opposing view. Profferred causative explanations are based on loose associations between trends in morbidity, mortality, and the factors of prevention and treatment and on unverifiable assumptions. Explanations of mortality trends for chronic diseases have seldom been satisfactory because of limitations in causeof-death information on death certificates and because accurate and comparable time trends for cardiovascular disease incidence and case-fatality have been lacking. There is no unequivocal explanation as to why coronary heart disease mortality had risen so high in the first place, nor is it clear why mortality for stroke, hypertension, and all cardiovascular diseases have been declining since 1940 or earlier, antidating antihypertensive therapy. We don't know why the coronary decline began first in women. Moreover, a strong case can be made for general influences on health operating on the entire population since the decline in cardiovascular mortality has been universal, in both sexes, in all races, and in all age groups. This universality is unprecedented. The fact that rates for the noncardiovascular causes of death are also declining, as described earlier, reinforces the suggestion that there are general health-promoting factors at work.
Trend data in coronary heart disease incidence and case-fatality are not available on a national basis, and studies such as that in Rochester life, they would still have a small impact on total coronary mortality.
An attempt to correlate geographic differences in coronary mortality with geographic differences in risk factor levels was not successful. Likewise, an attempt to match trends in cigarette smoking by age, race, and sex with the reversal in coronary heart disease mortality trends have not strongly linked the two. In fact, no one has yet established a convincing fit of trends for any risk factor with cardiovascular mortality trends. Inconsistencies in associations of this kind are also seen abroad. The heart disease death rate in Switzerland declined 13% for men and 40% for women between 1951 and 1976, while consumption of animal fats per capita increased by 20%. Also, smoking increased among women and did not decline appreciably among men. Fat consumption and serum cholesterol levels have increased in Japan at the same time as coronary heart disease mortality has been reported to be in decline. In England there has been a decline in cigarette smoking but not in coronary heart disease mortality.
Implications and conclusions
The declines in cardiovascular mortality clearly imply that these major forces of morbidity and mortality are controllable. Whether one subscribes to the notion that those improvements are chiefly a result of changes in disease-promoting lifestyles or a result of better medical care for those already afflicted, it is clear that these diseases are not inevitable burdens of aging and genetic make-up. While a genetic susceptibility is likely, the dramatic turnaround in coronary heart disease mortality over two decades surely indicates a powerful environmental influence.
Although data fall short of proving or disproving the specific impacts of increased public awareness of symptoms of impending strokes or coronary attacks, mass training in cardiopulmonary resuscitation, emergency life-support services, improved hospital care, and efforts to reduce cardiovascular risk factors in the population, it is likely that one or more of these has had an effect. Unfortunately, too little is known about how these efforts have influenced trends in coronary attack, out-of-hospital sudden death, and hospital case-fatality rates. Better Over the past three decades adult mortality rates have improved so that adults are sharing with infants in gains in life expectancy, and these recent gains are chiefly a result of reduced cardiovascular mortality. While this improvement is to an extent attributable to better clinical management, it is likely that efforts to change the cardiovascular risk have played a larger role. The success in changing behavior patterns affecting health is a remarkable phenomenon. History records few instances in which disease has been prevented by motivating people to give up practices they like for future benefits in health. Most health gains in the past have resulted from community-wide measures to alter the ecology rather than by individual action.
The proportionally greater gain in life expectancy in adults relative to newborns in recent decades suggests that cardiovascular health problems have been for the most part identified and dealt with effectively. This suggests the possibility of making even greater gains.
Although the explanation for the declines in cardiovascular mortality remains speculative, they are not artifactual, they are substantial, and they have now been sustained for more than a decade. This accelerating decline has coincided with increased efforts to achieve healthier living habits. Since there has been an accompanying decline in noncardiovascular mortality, those concerned about alleged harmful effects of proposed risk factor control should be reassured.
It seems likely that the improvement in cardiovascular mortality will continue if the public and the medical profession strive to maintain its preventive efforts. If much of the improvement has in fact resulted from changes in lifestyle, as appears to be the case, this should be encouraged since the fate of the potential coronary disease candidate appears to be in his or her own hands.
